Growth inhibition of Candida species by Wickerhamomyces anomalus mycocin and a lactone compound of Aureobasidium pullulans

BACKGROUND: The increasing resistance of Candida yeasts towards antifungal compounds and the limited choice of therapeutic drugs have spurred great interest amongst the scientific community to search for alternative anti-Candida compounds. Mycocins and fungal metabolites have been reported to have t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tay, Sun-Tee, Lim, Su-Lin, Tan, Hui-Wee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246603/
https://www.ncbi.nlm.nih.gov/pubmed/25380692
http://dx.doi.org/10.1186/1472-6882-14-439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246603/
https://www.ncbi.nlm.nih.gov/pubmed/25380692
http://dx.doi.org/10.1186/1472-6882-14-439

Ejemplares similares